X4 Pharmaceuticals, Inc - FORM S-1 - EX-21.1 - October 20, 2017

Attached files

file filename
EX-10.31 - EX-10.31 - X4 Pharmaceuticals, Incd427310dex1031.htm
EX-10.39 - EX-10.39 - X4 Pharmaceuticals, Incd427310dex1039.htm
S-1 - S-1 - X4 Pharmaceuticals, Incd427310ds1.htm
EX-23.1 - EX-23.1 - X4 Pharmaceuticals, Incd427310dex231.htm
EX-10.41 - EX-10.41 - X4 Pharmaceuticals, Incd427310dex1041.htm
EX-10.40 - EX-10.40 - X4 Pharmaceuticals, Incd427310dex1040.htm
EX-10.38 - EX-10.38 - X4 Pharmaceuticals, Incd427310dex1038.htm
EX-10.37 - EX-10.37 - X4 Pharmaceuticals, Incd427310dex1037.htm
EX-10.36 - EX-10.36 - X4 Pharmaceuticals, Incd427310dex1036.htm
EX-10.35 - EX-10.35 - X4 Pharmaceuticals, Incd427310dex1035.htm
EX-10.34 - EX-10.34 - X4 Pharmaceuticals, Incd427310dex1034.htm
EX-10.33 - EX-10.33 - X4 Pharmaceuticals, Incd427310dex1033.htm
EX-10.32 - EX-10.32 - X4 Pharmaceuticals, Incd427310dex1032.htm
EX-10.30 - EX-10.30 - X4 Pharmaceuticals, Incd427310dex1030.htm
EX-10.29 - EX-10.29 - X4 Pharmaceuticals, Incd427310dex1029.htm
EX-10.28 - EX-10.28 - X4 Pharmaceuticals, Incd427310dex1028.htm
EX-10.27 - EX-10.27 - X4 Pharmaceuticals, Incd427310dex1027.htm
EX-10.26 - EX-10.26 - X4 Pharmaceuticals, Incd427310dex1026.htm
EX-10.25 - EX-10.25 - X4 Pharmaceuticals, Incd427310dex1025.htm
EX-10.24 - EX-10.24 - X4 Pharmaceuticals, Incd427310dex1024.htm
EX-10.23 - EX-10.23 - X4 Pharmaceuticals, Incd427310dex1023.htm
EX-10.22 - EX-10.22 - X4 Pharmaceuticals, Incd427310dex1022.htm
EX-10.21 - EX-10.21 - X4 Pharmaceuticals, Incd427310dex1021.htm
EX-10.20 - EX-10.20 - X4 Pharmaceuticals, Incd427310dex1020.htm
EX-10.19 - EX-10.19 - X4 Pharmaceuticals, Incd427310dex1019.htm
EX-10.18 - EX-10.18 - X4 Pharmaceuticals, Incd427310dex1018.htm
EX-10.17 - EX-10.17 - X4 Pharmaceuticals, Incd427310dex1017.htm
EX-10.16 - EX-10.16 - X4 Pharmaceuticals, Incd427310dex1016.htm
EX-10.15 - EX-10.15 - X4 Pharmaceuticals, Incd427310dex1015.htm
EX-10.14 - EX-10.14 - X4 Pharmaceuticals, Incd427310dex1014.htm
EX-10.13 - EX-10.13 - X4 Pharmaceuticals, Incd427310dex1013.htm
EX-10.12 - EX-10.12 - X4 Pharmaceuticals, Incd427310dex1012.htm
EX-10.11 - EX-10.11 - X4 Pharmaceuticals, Incd427310dex1011.htm
EX-10.10 - EX-10.10 - X4 Pharmaceuticals, Incd427310dex1010.htm
EX-10.9 - EX-10.9 - X4 Pharmaceuticals, Incd427310dex109.htm
EX-10.8 - EX-10.8 - X4 Pharmaceuticals, Incd427310dex108.htm
EX-10.7 - EX-10.7 - X4 Pharmaceuticals, Incd427310dex107.htm
EX-10.6 - EX-10.6 - X4 Pharmaceuticals, Incd427310dex106.htm
EX-10.5 - EX-10.5 - X4 Pharmaceuticals, Incd427310dex105.htm
EX-10.4 - EX-10.4 - X4 Pharmaceuticals, Incd427310dex104.htm
EX-10.3 - EX-10.3 - X4 Pharmaceuticals, Incd427310dex103.htm
EX-10.2 - EX-10.2 - X4 Pharmaceuticals, Incd427310dex102.htm
EX-10.1 - EX-10.1 - X4 Pharmaceuticals, Incd427310dex101.htm
EX-4.1 - EX-4.1 - X4 Pharmaceuticals, Incd427310dex41.htm
EX-3.4 - EX-3.4 - X4 Pharmaceuticals, Incd427310dex34.htm
EX-3.3 - EX-3.3 - X4 Pharmaceuticals, Incd427310dex33.htm
EX-3.2 - EX-3.2 - X4 Pharmaceuticals, Incd427310dex32.htm
EX-3.1 - EX-3.1 - X4 Pharmaceuticals, Incd427310dex31.htm

Exhibit 21.1

List of Subsidiaries

The following is the name, jurisdiction of organization and percentage ownership by the Company of its Subsidiary.

 

     JURISDICTION
OF
INCORPORATION		    COMPANY
OWNED BY
PERCENTAGE		  

Arsanis Biosciences GmbH

    Austria      100 % 

X4 Pharmaceuticals, Inc Reports